Innogenix, LLC.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 8200 New Horizons Blvd, Amityville, New York (NY) 11701, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3013326213 · DUNS 044649124
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIBioresearch Monitoring2025-03-13
- VAIDrug Quality Assurance2024-11-15
- NAIDrug Quality Assurance2018-05-14
Drugs this plant is listed as making
8 distinct drugs across 30 products name this site in their FDA label.
- BaclofenXLCare Pharmaceuticals Inc.
- captoprilAmici Pharmaceuticals Llc
- HaloperidolInnogenix, Inc.
- MetolazoneAmici Pharma, Inc
- metronidazolein shortageAmici Pharma Inc
- Propranolol Hydrochloridein shortageAmici Pharmaceuticals Llc
- RamelteonKanchan Healthcare Inc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.